At-home patient self-monitoring of warfarin therapy yielded similar results to monitoring performed in a clinic setting and randomized trials, particularly among those who self-tested on a weekly ...

The voluntary recall does not include the Alere INRatio PT/INR Test Strip (PN 100071), which is utilized by patient self-testers for home INR monitoring.

Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows ... Alere Inc, San Diego, CA (GD, KK); Alere Home Monitoring Inc, Livermore ...

Alternate methods of PT/INR testing, such as plasma-based laboratory INR test, or the use of an alternate Alere product or point-of-care monitoring system is recommended.

WALTHAM, Mass., Dec. 8, 2014 /PRNewswire/ -- Alere Inc. has initiated a voluntary correction to inform U.S. users of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitor system of certain medical ...

Alere has announced a voluntary withdrawal of the Alere INRatio and INRatio 2 PT/INR Monitoring System. Menu SECTIONS. Home; Drug ... McKnight’s Home Care. McKnight’s Long-term Care. McKnight ...

Alere INRatio® and INRatio®2 PT/INR Monitor Systems: INRatio Patient Self-Test Kit ; INRatio PT Professional Kit ; INRatio2 Prothrombin Time (PT) Monitoring System, Professional ; ...

WALTHAM, Mass. - Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. (NYSE:ALR) will be initiating a voluntary withdrawal of the Alere INRatio and ...

The Alere INRatio and INRatio2 PT/INR monitoring systems will be withdrawn from the market because of the potential for the monitors to give inaccurate INR results. X. No Results.

Blood pressure levels improved in 98.4% of pilot population ATLANTA--(BUSINESS WIRE)-- Recent data from a year-long pilot study performed by Alere Health found that at-home blood pressure monitoring ...